2019
Achievement of Target Doses of Guideline-Directed Medical Therapy Prior to Cardiac Resynchronization Therapy is Suboptimal
Balakumaran K, Goldgrab D, Krishnan A, Shah N, Kim M, Rabieihashemi S, Cipriani K, Pickett C, Tabtabai S. Achievement of Target Doses of Guideline-Directed Medical Therapy Prior to Cardiac Resynchronization Therapy is Suboptimal. Journal Of Cardiac Failure 2019, 25: s128. DOI: 10.1016/j.cardfail.2019.07.366.Peer-Reviewed Original ResearchGuideline directed medical therapyCardiac resynchronization therapyCardiac resynchronization therapy implantationHeart failureTarget doseTime of implantationCRT implantationResynchronization therapyMedical therapyDosing of guideline-directed medical therapyGuideline-directed medical therapyDirected medical therapyNYHA class IIIII heart failureDocumented atrial fibrillationProportion of patientsDevice-based treatmentBackground Heart failureBB therapyHF registryIschemic cardiomyopathyClinical characteristicsChart reviewDevice therapyAtrial fibrillation
2018
Updates in heart failure 30-day readmission prevention
Goldgrab D, Balakumaran K, Kim M, Tabtabai S. Updates in heart failure 30-day readmission prevention. Heart Failure Reviews 2018, 24: 177-187. PMID: 30488242, DOI: 10.1007/s10741-018-9754-4.Peer-Reviewed Original ResearchConceptsHospital Readmissions Reduction ProgramAffordable Care ActReduce health care costsReadmission ratesReduce short-term readmissionsReadmissions Reduction ProgramHF readmissionHealth care costsCare costsShort-term readmissionCare ActAdmission diagnosisPrevent heart failureReduction programsRemote hemodynamic monitoringReadmissionMedical therapyHeart failureHF patientsHemodynamic monitoringHospitalProgram